Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
TEPMETKO Filmtabl 225 mg 60 Stk
Drug
Tepmetko, Filmtabletten
Behandlung von nicht-kleinzelligem Lungenkarzinom mit MET-Alterationen
07.16. – oncologicals
HAM – Human medicine
FILM – Film-coated tablet
S – synthetic products for human use
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
6/22/2021
12/14/2028
Dosage strength
Tepmetko 225 mg, Filmtabletten
Behandlung von nicht-kleinzelligem Lungenkarzinom mit MET-Alterationen
01
Z – approved
Package
7680681130017
In trade from / since 8/11/2021
A/R – Authorised / referenced
60 tablet(s)
001
Z – approved
Declaration
Component
225 mg tepotinibum
250 mg tepotinibi hydrochloridum monohydricum
250 mg tepotinibi hydrochloridum monohydricum
455.33 mg mannitolum
cellulosum microcristallinum
crospovidonum
magnesii stearas
silica colloidalis anhydrica
hypromellosum
4.37 mg lactosum monohydricum
macrogola
triacetinum
E 171
E 172 (rubrum)
cellulosum microcristallinum
crospovidonum
magnesii stearas
silica colloidalis anhydrica
hypromellosum
4.37 mg lactosum monohydricum
macrogola
triacetinum
E 171
E 172 (rubrum)
Spezialitätenliste***
SL
-
-
6445.20
None
Yes
10%
No
Authorisation holder
7601001004542
Merck (Schweiz) AG
Chamerstrasse 174
6300 Zug (ZG)
Chamerstrasse 174
6300 Zug (ZG)
Date of revision of the text
7/4/2024
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.